Endpoint-only views lack the cross-domain context and timeliness needed for prevention. Using multiple point solutions for different aspects of security only increases dashboard fatigue, making it ...

Investing.com -- AstraZeneca PLC (ST:AZN) announced Monday that its LATIFY Phase III trial of ceralasertib in combination ...

Ipsen’s phase II FALKON trial in patients with ultra-rare bone disease, fibrodysplasia ossificans progressiva fails to meet primary endpoint: Paris, France Monday, December 22, ...

Investing.com -- AstraZeneca PLC (NASDAQ:AZN) announced Monday that its LATIFY Phase III trial of ceralasertib failed to meet its primary endpoint in non-small cell lung cancer (NSCLC).

Although there are several effective anti-osteoporosis drugs on the market today, new therapies with improved safety profiles and efficacy are still needed. The FDA called osteoporosis-related ...

At the San Antonio Breast Cancer Symposium, investigators reported phase III results showing that the oral selective estrogen ...

Discover why CrowdStrike Holdings, Inc. is the top cybersecurity stock for 2026, showing rapid growth and big upside. Click for this CRWD stock update.

Recent industry reports consistently show that over 80% of breaches involve human error, whether through phishing, credential ...

The adoption of the FAIR model was pivotal in transforming our cybersecurity strategy into a measurable, business-aligned framework.

Pfizer is pursuing pipeline expansions through the Metsera acquisition and a major licensing deal with 3SBio. Find out why ...

AI-powered analytics, automation, and behavioral monitoring are redefining how organizations detect and respond ...

Susan Galbraith, AstraZeneca’s executive vice president for oncology haematology R&D, discussed the setback in a statement. Galbraith said the goal was to “reinvigorate the immune response of patients ...